Target-funded study highlights cost of hunger in Minnesota
ST. PAUL, Minn. — A Target-funded study, conducted by the University of Minnesota Food Industry Center, found that hunger costs Minnesota residents more than $1.62 billion annually in direct and indirect health and education costs.
The study found that hunger leads to poorer health and education outcomes. For example, Minnesotans pay $925 million in such annual direct medical expenditures as hospitalizations and medications related to hunger, as well as $333 million annually in such indirect medical expenditures as treating headaches and colds. Furthermore, the study found hungry teens likely will develop depression, while hungry adults more likely will be obese or have Type 2 diabetes.
To close the hunger gap in the state, Target has pledged 60,000 lbs. of nonperishable items to the Hunger-Free Minnesota coalition, which seeks to change the way individuals, organizations and governments view and respond to hunger. Target’s donations are part of the company’s continuing involvement in hunger relief nationwide. The coalition includes six Minnesota food banks.
In related news, Minnesota Public Radio is partnering with the collaboration to underscore hunger awareness with events and radio and digital promotions.
Click here to learn more about Hunger-Free Minnesota.
GNC to sell branded retail, food-service equipment
LOS ANGELES General Nutrition Centers has inked a deal to sell its retail and food-service equipment with the help of IMG Licensing and The Legacy Cos.
IMG’s licensing agreement for GNC with The Legacy Cos. will give way to the creation of GNC-branded products, such as blenders and juicers, which will be distributed in the company’s stores. The products will retail from $150 to $400, IMG said.
The agreement will run through 2015.
“GNC has set the standard as an industry leader in the nutritional supplement business and is truly dedicated to helping its customers improve health and quality of life. Teaming up with The Legacy Cos. to expand its brand and create this new and exciting product line will continue to solidify GNC’s brand and its commitment to providing exceptional products and services to consumers,” said Tim Rothwell, IMG EVP and co-managing director of worldwide licensing.
Added GNC EVP Tom Dowd, “GNC is very excited to partner with a high-quality manufacturer that can produce a variety of products that complement the healthy lifestyle of our customers.”
Perrigo seeks approval for generic Zegerid OTC, Schering-Plough files suit
ALLEGAN, Mich. Perrigo has filed for regulatory approval of a generic version of an over-the-counter medication for frequent heartburn, prompting a lawsuit from the branded version’s manufacturer.
The company announced Friday that it had filed for approval for omeprazole and sodium bicarbonate in the 20 mg/1,100 mg strength. The medication is a generic version of Zegerid OTC, made by Schering-Plough HealthCare, a subsidiary of Merck.
Schering-Plough filed a lawsuit Monday alleging patent infringement in the U.S. District Court for the District of New Jersey to prevent Perrigo’s commercialization of the product.
Zegerid had sales of around $60 million during the 12-month period ended in the “most recent month,” according to SymphonyIRI Group.